Professor, Medicine, University Massachusetts Medical School
Gastroenterology
Dr. Gyongyi Szabo, MD
|
|
Give Review
Gyongyi Szabo is an expert in the field of Gastroenterology. He has 1 awards "Fellow (AGAF)". Gyongyi Szabo is a published doctor. He has 48 papers published. The most current publication "Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1α activation." He accepts all Medicare patients.
Publications
- Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatoHepatitis in mice.
- Alcohol-Induced miR-27a Regulates Differentiation and M2 Macrophage Polarization of Normal Human Monocytes.
- Alcoholic hepatitis and HCV interactions in the modulation of liver Disease.
- Krüppel-like factor 4 is a transcriptional regulator of M1/M2 macrophage polarization in alcoholic liver Disease.
- MicroRNAs in alcoholic liver Disease.
- Exosomes from Hepatitis C Infected Patients Transmit HCV Infection and Contain Replication Competent Viral RNA in Complex with Ago2-miR122-HSP90.
- A Novel Human Radixin Peptide Inhibits Hepatitis C Virus Infection at the Level of Cell Entry.
- Micro-RNA-155 Deficiency Prevents Alcohol-Induced Serum Endotoxin Increase and Small Bowel Inflammation in Mice.
- Innate immune cell networking in Hepatitis C virus infection.
- microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatoHepatitis.
- High fat diet feeding results in gender specific steatoHepatitis and inflammasome activation.
- Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages.
- Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatoHepatitis.
- Immune and inflammatory pathways in NASH.
- CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of Hepatitis C virus-infected cells and induction of interferon-alpha.
- STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver Disease.
- Differences in innate immune signaling between alcoholic and non-alcoholic steatoHepatitis.
- Human ezrin-moesin-radixin proteins modulate Hepatitis C virus infection.
- IFN-γ production by human natural killer cells in Response to HCV-infected hepatoma cells is dependent on accessory cells.
- MicroRNAs in liver Disease.
- Alcohol-induced IL-1? in the brain is mediated by NLRP3/ASC inflammasome activation that amplifies neuroinflammation.
- Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study.
- Toll-like receptors in liver Disease.
- Alcohol Facilitates HCV RNA Replication Via Up-Regulation of miR-122 Expression and Inhibition of Cyclin G1 in Human Hepatoma Cells.
- Response to letter to Editor, re: HEP-12-1345 "circulating microrna-122 signature in NAFLD and cardiovascular disease: A new endocrine System in metabolic syndrome"
- Innate immunity and alcoholic liver Disease.
- Human Type 2 Myeloid Dendritic Cells Produce Interferon-û and Amplify Interferon-ñ in Response to Hepatitis C Virus Infection.
- Inflammasomes in liver Diseases.
- Ethanol facilitates HCV replication via upregulation of GW182 and HSP90 in human hepatoma cells.
- The Presence of p47phox in Liver Parenchymal Cells is a Key Mediator in the Pathogenesis of Alcoholic Liver Steatosis.
- Induction of Bcl-3 by acute binge alcohol results in Toll-like receptor 4/LPS tolerance.
- Molecular hepatic carcinogenesis: impact of inflammation.
- Plasma microRNA profiles distinguish lethal injury in acetaminophen toxicity: A research study.
- Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced and inflammatory liver Diseases.
- Novel developmental biology-based protocol of embryonic stem cell differentiation to morphologically sound and functional yet immature hepatocytes.
- MicroRNA Signature in Alcoholic Liver Disease.
- MicroRNA silencing and the development of novel therapies for liver Disease.
- Signalling pathways in alcohol-induced liver inflammation.
- VSL#3 probiotic treatment attenuates fibrosis without changes in steatoHepatitis in a diet-induced nonalcoholic steatoHepatitis model in mice.
- Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes.
- The critical role of toll-like receptor (TLR) 4 in alcoholic liver Disease is independent of the common TLR adapter MyD88.
- Bone marrow-derived Immune cells mediate sensitization to liver injury in a myeloid differentiation factor 88-dependent fashion.
- Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals.
- Alcohol and HCV: Implications for Liver Cancer.
- Chronic Alcohol-Induced microRNA-155 Contributes to Neuroinflammation in a TLR4-Dependent Manner in Mice.
- The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatoHepatitis.
- Alcoholic hepatitis accelerates early hepatobiliary Cancer by increasing stemness and miR-122-mediated HIF-1α activation.
Schools
University Medical School Of Debrecen
University Med School
University Ma Med School
Health Institute University Innsbruck
University Hospital
University Ma Med Center
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Connecticare
- Fallon Community Health Plan
- First Health (Coventry Health Care) PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Network Health
- Tufts Health Plans
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Fellow (AGAF)
Education
-
University of Massachusetts -
University of Debrecen Medical and Health Science Center
Hospital
-
UMass Memorial Medical Center
Drug Facts
| NPI NUMBER | 1649253568 | |
| NPPES Provider LastName | SZABO | |
| NPPES Provider FirstName | GYONGYI | |
| NPPES Provider ZIPCode | 016550002 | |
| NPPES Provider State | MA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 101.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1649253568 |
| Last Name Of The Provider | SZABO |
| First Name Of The Provider | GYONGYI |
| View All |
Similar Doctors
|
|
Dr. Walter M. Kim, MD |
|
|
Dr. Edward Belkin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin J. Hyatt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pavan Manchikalapati, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Calvin Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Veronica N. Baptista, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kanishka Bhattacharya, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Isabel A. Zacharias, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Papper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rashmi V. Patwardhan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Graham F. Barnard, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Elise A. Jacques, MD
This Doctor is OpenDoctor Recommended.
|